Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008

Charles F Levenback; Ate G J van der Zee; Lukas Rob; Marie Plante; Al Covens; Achim Schneider; Robert Coleman; Eugenio Solima; Hermann Hertel; Emmanuel Barranger; Andreas Obermair; Michel Roy

doi:10.1016/j.ygyno.2009.03.035

Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008

Gynecol Oncol. 2009 Aug;114(2):151-6. doi: 10.1016/j.ygyno.2009.03.035.

Authors

Charles F Levenback¹, Ate G J van der Zee, Lukas Rob, Marie Plante, Al Covens, Achim Schneider, Robert Coleman, Eugenio Solima, Hermann Hertel, Emmanuel Barranger, Andreas Obermair, Michel Roy

Affiliation

¹ Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. clevenba@mdanderson.org

PMID: 19457548
DOI: 10.1016/j.ygyno.2009.03.035

Abstract

An expert panel was formed for the 6th biennial International Sentinel Node Society to review the status of sentinel lymph node biopsy (SLNB) in gynecologic oncology. This paper presents the opinion of the experts who participated regarding indications for SLNB, technical considerations, and directions for future investigation.

Publication types

Congress

MeSH terms

Female
Genital Neoplasms, Female / pathology*
Humans
Lymph Nodes / pathology*
Lymphatic Metastasis
Sentinel Lymph Node Biopsy / methods*
Sentinel Lymph Node Biopsy / standards